You'd hope the extra (US) $20m budgeted and (US) $8.2m already spent on Nextsteillis Sales and Promotions get a wriggle on then - $35m seems a fair way away.
Putting the Nextstellis 1H23 results into context, agree Revenue increased $7.1m (122%), but we spent an extra $7.6m on S&M ?!?!?!?!?!?!?! So essentially we lost more... WTF!!!!!
This needs to be sorted and there needs to be financial accountability for the Department and the individual Sales Staff. The commentary around this was a big tick for the new Executive.
Nextstellis isn't going to float the boat so to speak. It is the TmD products - assuming the S&M budget for the division *doesn't increase* significantly, then the *Gross Profit* from these sales will be close to the *Net Profit*.
Hate the use of Gross Profit when it show a massive 80% return before you consider that you spent 300% of revenue on expenses to achieve that...
- Forums
- ASX - By Stock
- Ann: Change in substantial holding
MYX
mayne pharma group limited
Add to My Watchlist
3.27%
!
$5.03

You'd hope the extra (US) $20m budgeted and (US) $8.2m already...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.03 |
Change
-0.170(3.27%) |
Mkt cap ! $408.6M |
Open | High | Low | Value | Volume |
$5.20 | $5.21 | $5.03 | $2.804M | 555.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14654 | $5.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.14 | 3111 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 5.010 |
2 | 61000 | 5.000 |
2 | 2200 | 4.990 |
2 | 702 | 4.970 |
3 | 2200 | 4.950 |
Price($) | Vol. | No. |
---|---|---|
5.140 | 3111 | 2 |
5.150 | 19052 | 1 |
5.180 | 396 | 1 |
5.200 | 2000 | 1 |
5.300 | 10000 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |